Filing Flows › Inspire Medical Systems (INSP) › Capital expenditures
Inspire Medical Systems (INSP) capital expenditures by quarter
Inspire Medical Systems' capital expenditures were $7.5M in Q3 2026 (third quarter 2026), -18% from Q2 2026. Over the last 6 quarters it ranged from $7.5M (Q3 2026) to $10.7M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $7.5M | -18% | -28% |
| Q2 2026 | $9.2M | -6% | +2% |
| Q1 2026 | $9.7M | -9% | — |
| Q4 2025 | $10.7M | +2% | — |
| Q3 2025 | $10.4M | +16% | — |
| Q2 2025 | $9.0M | — | — |
Q3 2026 at a glance
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Inspire Medical Systems' capital expenditures?
Inspire Medical Systems' capital expenditures were $7.5M in Q3 2026 (third quarter 2026), -18% from Q2 2026.
How has Inspire Medical Systems' capital expenditures changed?
Over the last 6 quarters it ranged from $7.5M (Q3 2026) to $10.7M (Q4 2025).
Q3 2026 results → · How Inspire Medical Systems makes money →